Startups · AI

Principal Scientist, SOP & Workflow Automation Champion, AI for Drug Discovery (AIDD)

Genentech · South San Francisco · On-site

← All jobs
About Genentech

Genentech discovers, develops, manufactures and commercializes treatments for patients with serious and life-threatening medical conditions. Backed by North Carolina Biotechnology Center.

About the role

At Roche's AI for Drug Discovery (AIDD) group within the Computational Sciences Center of Excellence, we are architecting a vision for end-to-end computational drug discovery. Today, drug discovery workflows are fragmented—different models for different modalities, disconnected processes across teams, manual handoffs between discovery and development. Found on 1752vc Careers, the job board for startup and VC roles.

What they're looking for

  • Technical Foundation
  • PhD in Computer Science, Computational Biology, Bioinformatics, or related field, or equivalent advanced experience (8+ years building computational systems)
  • Deep expertise in workflow orchestration, data pipeline design, and software architecture (not just machine learning)
  • Proven experience designing systems that integrate heterogeneous data sources, models, and processes at scale
  • Strong proficiency in Python and modern ML frameworks (PyTorch, TensorFlow, JAX), familiarity with workflow tools (Nextflow, Snakemake, Airflow, or similar)
  • Understanding of software engineering practices: version control, testing, documentation, CI/CD pipelines
More about this role

A healthier future. It’s what drives us to innovate. To continuously advance science and ensure everyone has access to the healthcare they need today and for generations to come. Creating a world where we all have more time with the people we love. That’s what makes us Roche.

Advances in AI, data, and computational sciences are transforming drug discovery and development. Roche’s Research and Early Development organisations at Genentech (gRED) and Pharma (pRED) have demonstrated how these technologies accelerate R&D, leveraging data and novel computational models to drive impact. Seamless data sharing and access to models across gRED and pRED are essential to maximising these opportunities. The new Computational Sciences Center of Excellence (CoE) is a strategic, unified group whose goal is to harness the transformative power of data and Artificial Intelligence (AI) to assist our scientists in both pRED and gRED to deliver more innovative and transformative medicines for patients worldwide. ​

At Roche's AI for Drug Discovery (AIDD) group within the Computational Sciences Center of Excellence, we are architecting a vision for end-to-end computational drug discovery. Today, drug...

Read the full posting on Genentech's site ↗

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.